Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Recurrent conjunctival papilloma causing nasolacrimal duct obstruction.

Lauer SA.

Am J Ophthalmol. 1990 Nov 15;110(5):580-1. No abstract available.

PMID:
2240155
2.

Recurrent conjunctival papilloma causing nasolacrimal duct obstruction.

Migliori ME, Putterman AM.

Am J Ophthalmol. 1990 Jul 15;110(1):17-22. Review.

PMID:
2195893
3.

Conjunctival and canalicular papillomas and ichthyosis vulgaris.

Slade CS, Katz NN, Whitmore PV, Bardenstein DS.

Ann Ophthalmol. 1988 Jul;20(7):251-5.

PMID:
3178078
4.

The regression of recurrent conjunctival papillomas by lymphoblastoid interferon treatment.

Chiemchaisri Y, Dongosintr N, Wasi C, Wanachiwanawin W, Tuchinda C, Yenchitsomanus T, Jaruthasana I.

J Med Assoc Thai. 1990 Jul;73(7):406-13. No abstract available.

PMID:
2246629
5.

Compression of lacrimal sac by inverted papilloma arising in the maxillary sinus.

Campbell CH, Apt RK, Schimek RA.

South Med J. 1974 Jul;67(7):773-5. No abstract available.

PMID:
4834733
6.

Laser therapy of conjunctival papillomas.

Jackson WB, Beraja R, Codère F.

Can J Ophthalmol. 1987 Feb;22(1):45-7.

PMID:
3815157
7.

Nasolacrimal duct obstruction secondary to dermatofibrosarcoma protuberans.

Bryar P, Sun R, Ebroon D.

Ophthalmology. 2004 Jul;111(7):1398-400.

PMID:
15234144
8.

[Human papillomavirus 6/11 in conjunctival papilloma].

Michel JL, Guiguen Y, Léger F, Gain P, Valanconny C, Cambazard F.

Ann Dermatol Venereol. 1996;123(2):90-2. French.

PMID:
8761758
9.

Carbon dioxide laser therapy of recurrent squamous papilloma of the conjunctiva.

Schachat A, Iliff WJ, Kashima HK.

Ophthalmic Surg. 1982 Nov;13(11):916-8.

PMID:
7155513
10.

Histopathology of nasolacrimal duct obstruction compatible with localized sarcoidosis.

Vasquez RJ, Linberg JV, McCormick SA.

Ophthal Plast Reconstr Surg. 1988;4(3):147-51.

PMID:
3154734
11.

Bilateral nasolacrimal duct obstruction managed with endoscopic techniques.

Wong RJ, Gliklich RE, Rubin PA, Goodman M.

Arch Otolaryngol Head Neck Surg. 1998 Jun;124(6):703-6.

PMID:
9639483
12.

Nasolacrimal obstruction secondary to I(131) therapy.

Burns JA, Morgenstern KE, Cahill KV, Foster JA, Jhiang SM, Kloos RT.

Ophthal Plast Reconstr Surg. 2004 Mar;20(2):126-9.

PMID:
15083081
13.

Spontaneous regression of a conjunctival intraepithelial neoplastic tumor.

Morsman CD.

Arch Ophthalmol. 1989 Oct;107(10):1490-1.

PMID:
2803099
14.

Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.

Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, Kloos RT, Jhiang SM.

Ophthal Plast Reconstr Surg. 2005 Sep;21(5):337-44.

PMID:
16234694
15.

Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.

Lee JS, Jung G, Oum BS, Lee SH, Roh HJ.

Ophthalmology. 2000 Sep;107(9):1666-70.

PMID:
10964826
16.

Punctual and canalicular agenesis presented with congenital nasolacrimal duct obstruction.

Wang JK, Lai PC, Liao SL.

Graefes Arch Clin Exp Ophthalmol. 2002 Nov;240(11):960-1. No abstract available.

PMID:
12523359
17.
18.
19.

Adult nasolacrimal duct obstruction.

Shermetaro C, Gladstone GJ.

J Am Osteopath Assoc. 1994 Mar;94(3):229-32. Review.

PMID:
8200826
20.

Acquired nasolacrimal duct obstruction.

Mills DM, Meyer DR.

Otolaryngol Clin North Am. 2006 Oct;39(5):979-99, vii. Review.

PMID:
16982258

Supplemental Content

Support Center